These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
563 related articles for article (PubMed ID: 30122873)
1. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. Link A; Kupcinskas J World J Gastroenterol; 2018 Aug; 24(30):3313-3329. PubMed ID: 30122873 [TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. Valenzuela MA; Canales J; Corvalán AH; Quest AF World J Gastroenterol; 2015 Dec; 21(45):12742-56. PubMed ID: 26668499 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of microRNAs in preneoplastic gastric mucosa. Link A; Schirrmeister W; Langner C; Varbanova M; Bornschein J; Wex T; Malfertheiner P Sci Rep; 2015 Feb; 5():8270. PubMed ID: 25652892 [TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-22-3p Predicts the Malignant Progression of Precancerous Gastric Lesions from Intestinal Metaplasia to Early Adenocarcinoma. Chen TH; Chiu CT; Lee C; Chu YY; Cheng HT; Hsu JT; Wu RC; Yeh TS; Lin KH Dig Dis Sci; 2018 Sep; 63(9):2301-2308. PubMed ID: 29736829 [TBL] [Abstract][Full Text] [Related]
5. Expression Profile of miRNA-17-3p and miRNA-17-5p Genes in Gastric Cancer Patients with Helicobacter pylori Infection. Khayam N; Nejad HR; Ashrafi F; Abolhassani M J Gastrointest Cancer; 2021 Mar; 52(1):130-137. PubMed ID: 31997281 [TBL] [Abstract][Full Text] [Related]
6. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246 [TBL] [Abstract][Full Text] [Related]
7. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578 [TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs in gastric cancer. Ishiguro H; Kimura M; Takeyama H World J Gastroenterol; 2014 May; 20(19):5694-9. PubMed ID: 24914330 [TBL] [Abstract][Full Text] [Related]
9. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer. Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476 [TBL] [Abstract][Full Text] [Related]
10. Circulating miR-19a-3p and miR-483-5p as Novel Diagnostic Biomarkers for the Early Diagnosis of Gastric Cancer. Cheng J; Yang A; Cheng S; Feng L; Wu X; Lu X; Zu M; Cui J; Yu H; Zou L Med Sci Monit; 2020 Jun; 26():e923444. PubMed ID: 32487978 [TBL] [Abstract][Full Text] [Related]
11. Identification of CEACAM5 as a Biomarker for Prewarning and Prognosis in Gastric Cancer. Zhou J; Fan X; Chen N; Zhou F; Dong J; Nie Y; Fan D J Histochem Cytochem; 2015 Dec; 63(12):922-30. PubMed ID: 26374829 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis. Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388 [TBL] [Abstract][Full Text] [Related]
13. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis. Compare D; Rocco A; Liguori E; D'Armiento FP; Persico G; Masone S; Coppola-Bottazzi E; Suriani R; Romano M; Nardone G J Clin Pathol; 2011 Aug; 64(8):677-82. PubMed ID: 21617174 [TBL] [Abstract][Full Text] [Related]
14. Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer. Shimizu T; Marusawa H; Watanabe N; Chiba T Gastroenterol Clin North Am; 2015 Sep; 44(3):625-38. PubMed ID: 26314672 [TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers. Jamali L; Tofigh R; Tutunchi S; Panahi G; Borhani F; Akhavan S; Nourmohammadi P; Ghaderian SMH; Rasouli M; Mirzaei H J Cell Physiol; 2018 Nov; 233(11):8538-8550. PubMed ID: 29923196 [TBL] [Abstract][Full Text] [Related]
16. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer. Sawaki K; Kanda M; Kodera Y Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):657-670. PubMed ID: 29902383 [TBL] [Abstract][Full Text] [Related]
17. Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae. Shin CM; Kim N; Park JH; Kang GH; Kim JS; Jung HC; Song IS J Pathol; 2012 Mar; 226(4):654-65. PubMed ID: 22252584 [TBL] [Abstract][Full Text] [Related]
18. Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry. Kuligowski J; Sanjuan-Herráez D; Vázquez-Sánchez MA; Brunet-Vega A; Pericay C; Ramírez-Lázaro MJ; Lario S; Gombau L; Junquera F; Calvet X; Quintás G J Proteome Res; 2016 Aug; 15(8):2729-38. PubMed ID: 27384260 [TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA-133, microRNA-17 and microRNA-25 in serum and its potential diagnostic value in gastric cancer. ZiaSarabi P; Sorayayi S; Hesari A; Ghasemi F J Cell Biochem; 2019 Aug; 120(8):12376-12381. PubMed ID: 30861177 [TBL] [Abstract][Full Text] [Related]
20. Biomarkers of gastric cancer: Current topics and future perspective. Matsuoka T; Yashiro M World J Gastroenterol; 2018 Jul; 24(26):2818-2832. PubMed ID: 30018477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]